Low serum levels of vitamin D in idiopathic inflammatory myopathies
Open Access
- 1 April 2013
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 72 (4) , 512-516
Abstract
Objectives To evaluate serum levels of 25(OH) vitamin D in patients with idiopathic inflammatory myopathies (IIM) (polymyositis (PM), dermatomyosistis (DM), inclusion body myositis (IBM) and juvenile DM (JDM)) and to compare these with healthy controls. Methods Serum samples from 149 patients with IIM and 290 healthy controls matched for gender and the month of blood sampling were analysed for 25(OH) vitamin D. ORs for vitamin D classes with 95% CI were calculated using a matched (conditional) logistic regression model. Groups were compared by the Kruskal–Wallis test and p values Results Patients with IIM had significantly lower serum levels of 25(OH) vitamin D than healthy controls (median 39 (10–168) nmol/l vs 68 (19–197) nmol/l; p=0.0001). There was no significant difference in vitamin D levels between the myositis subgroups. When vitamin D levels were subclassified into deficient (Conclusions Low serum levels of vitamin D were found in most patients with IIM and may confer a risk factor for developing adult myositis, similar to some other autoimmune diseases.Keywords
This publication has 45 references indexed in Scilit:
- Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2011
- Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosisBrain, 2011
- Confirmation of association between multiple sclerosis and CYP27B1European Journal of Human Genetics, 2010
- Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathiesAnnals of the Rheumatic Diseases, 2009
- Elevated serum interferon‐α activity in juvenile dermatomyositis: Associations with disease activity at diagnosis and after thirty‐six months of therapyArthritis & Rheumatism, 2009
- UV Radiation Regulates Mi-2 through Protein Translation and StabilityJournal of Biological Chemistry, 2008
- A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti–Jo‐1 or anti–Ro 52/anti–Ro 60 autoantibodiesArthritis & Rheumatism, 2007
- Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategiesNature Clinical Practice Neurology, 2006
- Vitamin D deficiency in systemic lupus erythematosusAutoimmunity Reviews, 2006
- Anti-Jo-1 AntibodiesAutoimmunity, 2005